Skip to main content
Erschienen in: Pediatric Nephrology 9/2018

24.01.2018 | Clinical Quiz

Submandibular lymphadenopathy in a child post-renal transplant—“What lies beneath?!”: Answers

verfasst von: Gurinder Kumar, Mohammed Khair Al Ghabra, Sadia Hafez Ilyas, Vasudev Omprakash Sharma, Naser Al Zein, Eihab Al Khasawneh

Erschienen in: Pediatric Nephrology | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Excerpt

1.
The differential diagnosis to be considered for cervical/submandibular lymphadenopathy in a child post-renal transplant is as follows:
a)
Post-transplant lymphoproliferative disorder: usually associated with an Epstein–Barr virus infection. It may be insidious, resembling infectious mononucleosis, or it can present as an aggressive form of lymphoma.
 
b)
In an immunosuppressed child presenting with fever, pharyngitis, and cervical lymphadenopathy, the differential diagnosis may include streptococcal infection and infectious mononucleosis.
 
c)
Tuberculosis.
 
d)
Kikuchi–Fujimoto disease: rare benign and self-limiting disease with a worldwide distribution and higher prevalence in the Asian population, characterized by regional cervical lymphadenopathy accompanied by mild fever and night sweats.
 
e)
Viral lymphadenitis.
 
f)
Human immunodeficiency virus infection.
 
g)
Kaposi’s sarcoma.
 
 
2.
Histopathology demonstrated a lymph node that was completely replaced by a metastatic tumor. Fig. 1 shows metastatic Kaposi’s sarcoma (KS)—H&E (×200) stain displays bland spindle cell proliferation with slit-like spaces in between that contain red blood cells. Lymphoid cells are seen at one end. Fig. 2 shows immunohistochemistry (×200) where the spindle cells are strongly and diffusely positive for human herpesvirus-8 (HHV8), confirming KS. Ancillary studies (immunohistochemistry): CD34-positive, HHV8-positive, S100-positive in the dendritic cells. Smooth muscle actin/creatine kinase (CK) and AE1/AE3/CK5/6 were negative. Hence, the findings were consistent with metastatic KS.
 
3.
Management of KS of the lymph node involves reduction of immunosuppression, which is the initial management strategy. Changing the immunosuppression from calcineurin inhibitors to an mTOR inhibitor such as sirolimus can be considered because of its dual action of inhibiting the progression of KS and as an anti-rejection medication.
 
Literatur
1.
Zurück zum Zitat Geissler EK (2015) Post-transplantation malignancies: here today, gone tomorrow? Nat Rev Clin Oncol 12:705–717CrossRefPubMed Geissler EK (2015) Post-transplantation malignancies: here today, gone tomorrow? Nat Rev Clin Oncol 12:705–717CrossRefPubMed
2.
Zurück zum Zitat Einollahi B (2007) Kaposi sarcoma after kidney transplantation. Iran J Kidney Dis 1:2–11PubMed Einollahi B (2007) Kaposi sarcoma after kidney transplantation. Iran J Kidney Dis 1:2–11PubMed
3.
Zurück zum Zitat Hosseini-Moghaddam SM, Soleimanirahbar A, Mazzulli T, Rotstein C, Husain S (2012) Post renal transplantation Kaposi’s sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy. Transpl Infect Dis 14:338–345CrossRefPubMed Hosseini-Moghaddam SM, Soleimanirahbar A, Mazzulli T, Rotstein C, Husain S (2012) Post renal transplantation Kaposi’s sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy. Transpl Infect Dis 14:338–345CrossRefPubMed
4.
Zurück zum Zitat Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G (2005) Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 352:1317–1323CrossRefPubMed Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G (2005) Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 352:1317–1323CrossRefPubMed
Metadaten
Titel
Submandibular lymphadenopathy in a child post-renal transplant—“What lies beneath?!”: Answers
verfasst von
Gurinder Kumar
Mohammed Khair Al Ghabra
Sadia Hafez Ilyas
Vasudev Omprakash Sharma
Naser Al Zein
Eihab Al Khasawneh
Publikationsdatum
24.01.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 9/2018
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-017-3861-7

Weitere Artikel der Ausgabe 9/2018

Pediatric Nephrology 9/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.